Narimatsu S - Search Results

1

The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol.

Narimatsu S, Kazamori D, Masuda K, Katsu T, Funae Y, Naito S, Nakura H, Yamano S, Hanioka N. Narimatsu S, et al. Biochem Pharmacol. 2009 Mar 1;77(5):920-31. doi: 10.1016/j.bcp.2008.11.006. Epub 2008 Nov 17. Biochem Pharmacol. 2009. PMID: 19059219

2

Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19.

Hichiya H, Kuramoto S, Yamamoto S, Shinoda S, Hanioka N, Narimatsu S, Asaoka K, Miyata A, Iwata S, Nomoto M, Satoh T, Kiryu K, Ueda N, Naito S, Tucker GT, Ellis SW. Hichiya H, et al. Among authors: narimatsu s. Biochem Pharmacol. 2004 Jul 1;68(1):165-75. doi: 10.1016/j.bcp.2004.03.018. Biochem Pharmacol. 2004. PMID: 15183128

3

The roles of amino acid residues at positions 43 and 45 in microsomal contents and enzymatic functions of rat CYP2D1 and CYP2D2.

Narimatsu S, Imoto K, Isobe T, Kiryu K, Naito S, Hichiya H, Funae Y, Hanioka N, Yamamoto S. Narimatsu S, et al. Biochem Biophys Res Commun. 2004 Nov 12;324(2):627-33. doi: 10.1016/j.bbrc.2004.09.089. Biochem Biophys Res Commun. 2004. PMID: 15474473

4

Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.

Isobe T, Hichiya H, Hanioka N, Yamamoto S, Shinoda S, Funae Y, Satoh T, Yamano S, Narimatsu S. Isobe T, et al. Among authors: narimatsu s. Biol Pharm Bull. 2005 Apr;28(4):634-40. doi: 10.1248/bpb.28.634. Biol Pharm Bull. 2005. PMID: 15802801 Free article.

5

Roles of phenylalanine at position 120 and glutamic acid at position 222 in the oxidation of chiral substrates by cytochrome P450 2D6.

Masuda K, Tamagake K, Katsu T, Torigoe F, Saito K, Hanioka N, Yamano S, Yamamoto S, Narimatsu S. Masuda K, et al. Among authors: narimatsu s. Chirality. 2006 Feb;18(3):167-76. doi: 10.1002/chir.20246. Chirality. 2006. PMID: 16432914 Review.

6

Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.

Narimatsu S, Yonemoto R, Saito K, Takaya K, Kumamoto T, Ishikawa T, Asanuma M, Funada M, Kiryu K, Naito S, Yoshida Y, Yamamoto S, Hanioka N. Narimatsu S, et al. Biochem Pharmacol. 2006 Apr 28;71(9):1377-85. doi: 10.1016/j.bcp.2006.01.015. Epub 2006 Feb 28. Biochem Pharmacol. 2006. PMID: 16510126

7

Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: in vitro functional analysis of recombinant proteins expressed in Saccharomyces cerevisiae.

Hanioka N, Okumura Y, Saito Y, Hichiya H, Soyama A, Saito K, Ueno K, Sawada J, Narimatsu S. Hanioka N, et al. Among authors: narimatsu s. Biochem Pharmacol. 2006 Apr 28;71(9):1386-95. doi: 10.1016/j.bcp.2006.01.019. Epub 2006 Mar 9. Biochem Pharmacol. 2006. PMID: 16527257

8

Cloning of a cDNA encoding a novel marmoset CYP2C enzyme, expression in yeast cells and characterization of its enzymatic functions.

Narimatsu S, Torigoe F, Tsuneto Y, Saito K, Hanioka N, Masuda K, Katsu T, Yamamoto S, Yamano S, Baba T, Miyata A. Narimatsu S, et al. Biochem Pharmacol. 2006 Dec 15;72(12):1738-48. doi: 10.1016/j.bcp.2006.08.025. Epub 2006 Sep 29. Biochem Pharmacol. 2006. PMID: 17010942

9

Stereoselective hexobarbital 3'-hydroxylation by CYP2C19 expressed in yeast cells and the roles of amino acid residues at positions 300 and 476.

Saito K, Dan H, Masuda K, Katsu T, Hanioka N, Yamamoto S, Miyano K, Yamano S, Narimatsu S. Saito K, et al. Among authors: narimatsu s. Chirality. 2007 Jul;19(7):550-8. doi: 10.1002/chir.20412. Chirality. 2007. PMID: 17487889

10

Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.

Narimatsu S, Yonemoto R, Masuda K, Katsu T, Asanuma M, Kamata T, Katagi M, Tsuchihashi H, Kumamoto T, Ishikawa T, Naito S, Yamano S, Hanioka N. Narimatsu S, et al. Biochem Pharmacol. 2008 Feb 1;75(3):752-60. doi: 10.1016/j.bcp.2007.09.019. Epub 2007 Sep 29. Biochem Pharmacol. 2008. PMID: 17980859

This metabolic profile is different from our previous findings in human liver microsomal fractions, in which the aromatic ring O-demethylation was the major pathway whereas the side-chain N-deisopropylation was minor [Narimatsu S, Yonemoto R, Saito K, Takaya K, Kuma …

This metabolic profile is different from our previous findings in human liver microsomal fractions, in which the aromatic ring O-demethylati …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters